Opportunity Information: Apply for RFA GH 12 004
Apply for RFA GH 12 004
- The Centers for Disease Control and Prevention in the health sector is offering a public funding opportunity titled "Conducting Public Health Research in South Africa by the National Health Laboratory Service (NHLS)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.283 Centers for Disease Control and PreventionInvestigations and Technical Assistance.
- This funding opportunity was created on Dec 15, 2011 and posted on Dec 15, 2011.
- Applicants must submit their applications by Mar 1, 2012 Letter of Intent requested by February 1, 2012. Please see the full announcement document (click above) for further information.. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- The funding agency has allocated a total of $25,000,000.00 to eligible and selected applicants.
- Each selected applicant is eligible to receive up to $5,000,000.00 in funding.
- The number of recipients for this funding is limited to 1 candidate(s).
- Eligible applicants include: Others (see text field entitled Additional Information on Eligibility for clarification).
- Eligibility for this program is limited to the National Health Laboratory Service (NHLS), South Africa. No other applications are being solicited.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Opportunity Summary:
The grant opportunity titled "Conducting Public Health Research in South Africa by the National Health Laboratory Service (NHLS)" (Funding Opportunity Number RFA GH 12 004) is a CDC discretionary cooperative agreement designed to support a wide-ranging public health research agenda in South Africa through the NHLS. It sits under CFDA 93.283 (Centers for Disease Control and Prevention Investigations and Technical Assistance) and uses a cooperative agreement mechanism, which typically means the CDC expects to have substantial programmatic involvement alongside the awardee rather than serving only as a pass-through funder. The overall intent is to strengthen evidence generation in priority health areas and make sure that research findings do not stay in academic silos, but instead translate into real-world prevention, control, and preparedness programs.
At its core, the opportunity has two major goals. The first is to conduct both field and laboratory research on major human health threats. The infectious disease emphasis is broad and includes HIV/AIDS, tuberculosis, and influenza, along with other respiratory diseases and diarrheal diseases that drive significant illness and outbreaks. It also explicitly prioritizes emerging and re-emerging infectious diseases, neglected tropical diseases, and zoonotic diseases, reflecting concern about pathogens that can spill over from animals to humans and those with epidemic or pandemic potential. Beyond communicable diseases, the scope extends to environmental health issues and a range of additional public health priorities, including chronic diseases, maternal and child health, public health preparedness, biosafety, and injury control and prevention. In practical terms, this framing supports work that spans surveillance and outbreak investigation, diagnostics and laboratory science, epidemiologic field studies, risk factor research, and applied research that improves how public health systems detect, understand, and respond to health threats.
The second major goal focuses on translation and knowledge sharing. The CDC is not only funding research for publication, but specifically calling for research outputs to be incorporated into operational health promotion, disease prevention, and disease control programs within South Africa. This implies an expectation that findings will inform policy, guidelines, service delivery strategies, laboratory practices, and program design, and that results will be usable by public health implementers. In addition, the opportunity stresses sharing expertise and research findings with other nations as well as with non-governmental agencies and academic institutions, positioning the NHLS as a hub for regional and international collaboration, capacity building, and dissemination of best practices.
In terms of funding and award structure, the posting anticipated a single award (Expected Awards: 1), with an estimated total funding amount of $25,000,000 and an award ceiling of $5,000,000 (with no stated award floor). There is no cost sharing or matching requirement. The opportunity was posted on December 15, 2011, with an original and current closing date of March 1, 2012. A letter of intent was requested by February 1, 2012, which typically serves to help the agency plan for review and engagement, even when it is not always a binding requirement. The archive date is March 2, 2012, indicating the competition is no longer active.
Eligibility is extremely limited: the announcement states that eligibility is restricted to the National Health Laboratory Service (NHLS) in South Africa and that no other applications are being solicited. This makes the announcement effectively a targeted funding action rather than an open competition. For applicants or stakeholders seeking more detail, the notice directs readers to the full announcement document, and it provides a point of contact through the CDC Procurement and Grants Office Technical Information Management Section (TIMS) for technical access issues (phone: 770-488-2700).
Frequently Asked Questions (FAQs)
1. What is the title of this grant opportunity?
The opportunity is titled "Conducting Public Health Research in South Africa by the National Health Laboratory Service (NHLS)."
2. What is the Funding Opportunity Number (FON)?
The Funding Opportunity Number is RFA GH 12 004.
3. Which federal program is this opportunity associated with (CFDA)?
This opportunity is listed under CFDA 93.283, Centers for Disease Control and Prevention Investigations and Technical Assistance.
4. What type of funding mechanism is being used?
The mechanism is a CDC discretionary cooperative agreement.
5. What does "cooperative agreement" imply for how the CDC will participate?
A cooperative agreement typically means the CDC expects substantial programmatic involvement alongside the awardee, rather than acting only as a pass-through funder.
6. What is the overall intent of the opportunity?
The intent is to support a wide-ranging public health research agenda in South Africa through the NHLS, strengthen evidence generation in priority health areas, and promote the translation of research findings into real-world prevention, control, and preparedness programs.
7. What are the two major goals of this opportunity?
The two major goals are: (1) conducting field and laboratory research on major human health threats, and (2) translating and sharing knowledge so research outputs are incorporated into operational public health programs and shared with other nations and institutions.
8. What kinds of research activities does the opportunity support?
It supports both field and laboratory research, including work that spans surveillance and outbreak investigation, diagnostics and laboratory science, epidemiologic field studies, risk factor research, and applied research aimed at improving how public health systems detect, understand, and respond to health threats.
9. Which infectious diseases are specifically mentioned in the scope?
The announcement explicitly mentions HIV/AIDS, tuberculosis, and influenza, as well as other respiratory diseases and diarrheal diseases.
10. Does the opportunity include emerging or re-emerging disease threats?
Yes. It explicitly prioritizes emerging and re-emerging infectious diseases.
11. Are neglected tropical diseases included?
Yes. Neglected tropical diseases are explicitly included as priorities in the scope.
12. Are zoonotic diseases included?
Yes. Zoonotic diseases are explicitly prioritized, reflecting concerns about pathogens that can spill over from animals to humans and those with epidemic or pandemic potential.
13. Does the scope extend beyond communicable diseases?
Yes. The scope extends to environmental health issues and additional public health priorities, including chronic diseases, maternal and child health, public health preparedness, biosafety, and injury control and prevention.
14. What does the opportunity mean by "translation" of research findings?
It means the CDC is calling for research outputs to be incorporated into operational health promotion, disease prevention, and disease control programs in South Africa, rather than remaining only as academic publications.
15. What kinds of real-world uses of findings are implied?
The description implies findings should inform things like policy, guidelines, service delivery strategies, laboratory practices, and program design, and be usable by public health implementers.
16. Is sharing research and expertise outside South Africa part of the goals?
Yes. The opportunity stresses sharing expertise and research findings with other nations, as well as with non-governmental agencies and academic institutions.
17. How many awards were expected?
The posting anticipated a single award (Expected Awards: 1).
18. What was the estimated total funding amount?
The estimated total funding amount was $25,000,000.
19. What was the award ceiling?
The award ceiling was $5,000,000.
20. Was an award floor stated?
No award floor was stated.
21. Is cost sharing or matching required?
No. The opportunity states there is no cost sharing or matching requirement.
22. When was the opportunity posted?
The opportunity was posted on December 15, 2011.
23. What was the closing date for applications?
The original and current closing date listed was March 1, 2012.
24. Was a letter of intent requested?
Yes. A letter of intent was requested by February 1, 2012.
25. What is the stated purpose of the letter of intent?
Based on the description, it typically helps the agency plan for review and engagement, even when it is not always a binding requirement.
26. Is this funding opportunity still active?
No. The archive date is March 2, 2012, indicating the competition is no longer active.
27. Who is eligible to apply?
Eligibility is restricted to the National Health Laboratory Service (NHLS) in South Africa.
28. Are other organizations invited to apply?
No. The announcement states that no other applications are being solicited, making it a targeted funding action rather than an open competition.
29. Where does the notice direct readers for more detail?
It directs readers to the full announcement document for additional details.
30. Who can be contacted for technical access issues related to the announcement?
The notice provides a point of contact through the CDC Procurement and Grants Office Technical Information Management Section (TIMS) at 770-488-2700 for technical access issues.
Browse more opportunities from the same category: Health
Next opportunity: Lower Eastside Tenement Musuem
Previous opportunity: BLM OR WA McKenzie River Corridor Cooperative Maintenance Partnership, Lane County, Oregon
USGrants.org Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for RFA GH 12 004
[Watch] how do funding administrators access proposals?
Applicants also applied for:
Applicants who have applied for this opportunity (RFA GH 12 004) also looked into and applied for these:
| Funding Opportunity |
|---|
| Partnerships for Development of Therapeutics and Diagnostics for Biodefense (R01) Apply for RFA AI 12 017 Funding Number: RFA AI 12 017 Agency: National Institutes of Health Category: Health Funding Amount: $750,000 |
| Epidemiology, Prevention and Treatment of Influenza and Other Respiratory Infections in Ghana Apply for RFA IP 12 001 Funding Number: RFA IP 12 001 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: Case Dependent |
| Studies at the Animal Human Interface of Influenza and Other Zoonotic Diseases in Vietnam Apply for RFA IP 12 002 Funding Number: RFA IP 12 002 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: Case Dependent |
| Epidemiology, Prevention and Treatment of Influenza and Other Respiratory Infections in Panama and Central America Region Apply for RFA IP 12 006 Funding Number: RFA IP 12 006 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: Case Dependent |
| Morris K. Udall Centers of Excellence for Parkinsons Disease Research (P50) Apply for RFA NS 12 009 Funding Number: RFA NS 12 009 Agency: National Institutes of Health Category: Health Funding Amount: $1,500,000 |
| Research Dissemination and Implementation Grants (R18) Apply for PAR 12 063 Funding Number: PAR 12 063 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Public Health Conference Support Program Apply for CDC RFA EH12 1201 Funding Number: CDC RFA EH12 1201 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $200,000 |
| Research Grants for Preventing Violence and Violence Related Injury Apply for RFA CE 12 002 Funding Number: RFA CE 12 002 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $400,000 |
| Identifying Modifiable Protective Factors for Intimate Partner Violence or Sexual Violence Prevention Apply for RFA CE 12 003 Funding Number: RFA CE 12 003 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $350,000 |
| Regional Genetic and Newborn Screening Services Collaboratives Heritable Disorders Program Apply for HRSA 12 138 Funding Number: HRSA 12 138 Agency: Health Resources and Services Administration Category: Health Funding Amount: $600,000 |
| Healthy Start Initiative Eliminating Disparities in Perinatal Health (General Population) Apply for HRSA 12 016 Funding Number: HRSA 12 016 Agency: Health Resources and Services Administration Category: Health Funding Amount: $750,000 |
| Healthy Start Initiative Eliminating Disparities in Perinatal Health (Border, Alaska, and Hawaii) Apply for HRSA 12 017 Funding Number: HRSA 12 017 Agency: Health Resources and Services Administration Category: Health Funding Amount: $750,000 |
| Green Housing Study Follow up Measurements of Housing Factors and Respiratory Health of Children located in Cincinnati and Boston (U01) Apply for RFA EH 12 001 Funding Number: RFA EH 12 001 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $350,000 |
| HIV Early Intervention Services (EIS) Program Existing Geographic Service Areas (EISEGA) Apply for HRSA 12 076 Funding Number: HRSA 12 076 Agency: Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| Reducing Health Disparities among People with Intellectual Disabilities Apply for RFA DD 12 003 Funding Number: RFA DD 12 003 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $250,000 |
| Service Area Competition Additional Areas (Boydton, VA) Apply for HRSA 12 168 Funding Number: HRSA 12 168 Agency: Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| State Implementation Grants for Systems of Services for Children and Youth with Special Health Care Needs (CYSHCN) Apply for HRSA 12 049 Funding Number: HRSA 12 049 Agency: Health Resources and Services Administration Category: Health Funding Amount: $300,000 |
| New England Region AIDS Education and Training Center Program(s) (AETC) Apply for HRSA 12 124 Funding Number: HRSA 12 124 Agency: Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| Network and Infrastructure Support for Development of Interdisciplinary Aging Research (R24) Apply for PA 12 064 Funding Number: PA 12 064 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Human Heredity and Health in Africa (H3Africa) H3Africa Biorepository Grants (UH2/UH3) Apply for RFA RM 12 003 Funding Number: RFA RM 12 003 Agency: National Institutes of Health Category: Health Funding Amount: $115,000 |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Subscribe to Leads
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "RFA GH 12 004", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.